Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040995 | 0.83 | PKM (0.55) | SMN1; SMN2PKML3MBTL1 | |
| Hydrochloric Acid SCHEMBL9436628 | 0.80 | SLC9A1 (0.57) | SLC9A1 | |
| SCHEMBL18471225 | 0.80 | SMN1; SMN2 (0.49) | SMN1; SMN2L3MBTL1 | |
| SCHEMBL9436642 | 0.79 | VCAM1 (0.47) | SMN1; SMN2PKML3MBTL1 | |
| Hydrochloric Acid SCHEMBL9039986 | 0.78 | SLC9A1 (0.35) | SMN1; SMN2SLC9A1PKM | |
| SCHEMBL10177915 | 0.78 | L3MBTL1 (0.56) | SMN1; SMN2SLC9A1L3MBTL1 | |
| SCHEMBL17689083 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2SLC9A1L3MBTL1 | |
| SCHEMBL31401329 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2SLC9A1L3MBTL1 | |
| SCHEMBL3283017 | 0.73 | SLC9A1 (0.46) | SMN1; SMN2SLC9A1 | |
| SCHEMBL2435832 | 0.72 | L3MBTL1 (0.59) | SLC9A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111601790-B | Heteroaryl compounds as protein kinase inhibitors | 福建海西新药创制股份有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-116715625-A | Heteroaryl compounds as protein kinase inhibitors | 福建海西新药创制股份有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-111601790-B | Heteroaryl compounds as protein kinase inhibitors | 福建海西新药创制股份有限公司 | 2023-03-31 | — | — | CN | disclosed |